Multidrug-Resistant Pseudomonas aeruginosa : Risk Factors and Clinical Impact
Top Cited Papers
Open Access
- 1 January 2006
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 50 (1), 43-48
- https://doi.org/10.1128/aac.50.1.43-48.2006
Abstract
Pseudomonas aeruginosa , a leading nosocomial pathogen, may become multidrug resistant (MDR). Its rate of occurrence, the individual risk factors among affected patients, and the clinical impact of infection are undetermined. We conducted an epidemiologic evaluation and molecular typing using pulsed-field gel electrophoresis (PFGE) of 36 isolates for 82 patients with MDR P. aeruginosa and 82 controls matched by ward, length of hospital stay, and calendar time. A matched case-control study identified individual risk factors for having MDR P. aeruginosa , and a retrospective matched-cohort study examined clinical outcomes of such infections. The 36 isolates belonged to 12 PFGE clones. Two clones dominated, with one originating in an intensive care unit (ICU). Cases and controls had similar demographic characteristics and numbers of comorbid conditions. A multivariate model identified ICU stay, being bedridden, having high invasive devices scores, and being treated with broad-spectrum cephalosporins and with aminoglycosides as significant risk factors for isolating MDR P. aeruginosa . Having a malignant disease was a protective factor (odds ratio [OR] = 0.2; P = 0.03). MDR P. aeruginosa was associated with severe outcomes compared to controls, including increased mortality (OR = 4.4; P = 0.04), hospital stay (hazard ratio, 2; P = 0.001), and requirement for procedures (OR = 5.4; P = 0.001). The survivors functioned more poorly at discharge than the controls, and more of the survivors were discharged to rehabilitation centers or chronic care facilities. The epidemiology of MDR P. aeruginosa is complex. Critically ill patients that require intensive care and are treated with multiple antibiotic agents are at high risk. MDR P. aeruginosa infections are associated with severe adverse clinical outcomes.Keywords
This publication has 20 references indexed in Scilit:
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004American Journal of Infection Control, 2004
- The Impact of Antimicrobial Resistance on Health and Economic OutcomesClinical Infectious Diseases, 2003
- Antecedent Treatment with Different Antibiotic Agents as a Risk Factor for Vancomycin-ResistantEnterococcusEmerging Infectious Diseases, 2002
- Epidemiology and Clinical Outcomes of Patients with Multiresistant Pseudomonas aeruginosaClinical Infectious Diseases, 1999
- Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unitThorax, 1998
- Antibiotic Susceptibility of Multiply Resistant Pseudomonas aeruginosa Isolatedfrom Patients with Cystic Fibrosis, Including Candidates for TransplantationClinical Infectious Diseases, 1996
- Early Risk Factors for Postinjury Multiple Organ FailureWorld Journal of Surgery, 1996
- Predominant pathogens in hospital infectionsJournal of Antimicrobial Chemotherapy, 1992
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988
- Epidemiology of Infections Due to Pseudomonas aeruginosaClinical Infectious Diseases, 1984